Theraflu Lar Table for 16 pcs resorption

$6.03

Theraflu Lar Table for 16 pcs resorption

5 in stock

Quantity:

Description

Composition
Active substance:
benzoxonium chloride, 1 mg; lidocaine hydrochloride 1 mg;
Excipients:
sorbitol – 1 g (corresponding to approximately 17 kJ / 4 kcal), microcrystalline cellulose – 20 mg Macrogol 6000 – 25 mg maize starch – 55 mg Sodium saccharinate – 4 mg Sodium chloride – 10 mg Citric acid – 5 mg, magnesium stearate – 1 mg, orange flavor – 40 mg.
Description:
Lozenges white color with a yellowish shade, round, biconvex, with Zyma company logo (two triangles are arranged against each other with a certain offset) on one side and the code “OR” – on the reverse side, with orange smell.
Product form:
To 8 tablets are packed in blister PVC / PE / PVDC / Aluminum foil of the composite material. Two blister is placed together with instructions for use in a pile of cardboard.
Contraindications
Pregnancy; lactation (breast feeding); Children under 4 years of age; hypersensitivity to the drug; Hypersensitivity to the ammonium compounds.
Dosage
1 mg + 1 mg
Indications
Infectious and inflammatory diseases of the oral cavity and throat: pharyngitis; laryngitis; catarrhal angina; stomatitis; ulcerative gingivitis; adenoid (as an adjuvant).
Interaction with other drugs
Efficacy benzoxonium chloride reduced with the simultaneous use of anion-active agents, such as toothpaste. Ethanol increases absorption benzoxonium chloride.
Overdose
Symptoms: in case of accidental ingestion of high doses may be nausea, vomiting. The content of lidocaine preparation is insignificant and can not cause serious overdose symptoms. Treatment: It is recommended to drink milk or eat egg whites, whipped into the water.
pharmachologic effect
Pharmacological group:
R02AA20
Pharmacodynamics:
Antiseptic preparation for local application in an ENT-practice. Is a quaternary ammonium salt: N-benzyl, N-dodecyl N, N-di (2-hydroxyethyl) ammonium chloride. Due to the structure of the cation has membranotropic activity and has a strong antibacterial effect on Gram-positive and to a lesser extent gram-negative microorganisms. Benzoxonium also possesses antifungal and antiviral activity against membrane viruses (including influenza virus, parainfluenza and herpes). Lidocaine is a local anesthetic which, when inflammatory processes reduces pain in the throat when swallowing.
Pharmacokinetics:
Benzoxonium chloride is practically not absorbed. The man is not determined by the active substance in the blood. In body tissues the accumulation of the active substance has been detected. About 1% of the dose received benzoxonium chloride found in urine. Lidocaine is absorbed, and ingestion through the oral mucosa. Metabolized in the “first pass” through the liver. When administered orally, the bioavailability is about 35%. lidocaine metabolites are excreted in the urine, less than 10% of the active substance is excreted unchanged.
Pregnancy and breast-feeding
The drug is contraindicated for use in the I trimester of pregnancy and lactation (breast-feeding). Adequate and well-controlled clinical studies safety of the drug during pregnancy was conducted. Use of the drug in trimesters II and III is not recommended. There is no clinical data on the release of active substances in breast milk. However, the drug is not recommended for use during breastfeeding. In experimental studies have found no effect of the drug on reproductive function and development of the fetus.
Conditions of supply of pharmacies
Without recipe
side effects
Possible: local irritation; when used for more than 2 weeks – brown color reversible tongue and teeth. Rare: allergic reactions.
special instructions
During the use of the drug should avoid alcohol.
Storage conditions
The drug should be kept out of the reach of children, dry place at a temperature not higher than 30 ° C.
Dosing and Administration
Inside. Single dose – 1 tablet every 2-3 hours. When expressed symptoms of the disease: 1 tablet every 1-2 hours. The tablet should dissolve slowly in the mouth. The daily dose should not exceed 10 tablets. Children: drug TeraFlyu® LAR can be used for children from 4 years, 1 tablet every 2-3 hours. The daily dose should not exceed 6 tablets.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

GlaxoSmithKline Helsker

There are no reviews yet.

Add your review